ATH 0.00% 0.3¢ alterity therapeutics limited

nejm solanezumab, page-7

  1. 1,123 Posts.
    lightbulb Created with Sketch. 158
    Hi Hercules, sola = solanezumab.
    The trial is to try to target people earlier in the disease process. Will be interesting to see what happens to sola if PBT2 knocks it out of the park..! (Fingers crossed)
 
watchlist Created with Sketch. Add ATH (ASX) to my watchlist
(20min delay)
Last
0.3¢
Change
0.000(0.00%)
Mkt cap ! $15.96M
Open High Low Value Volume
0.3¢ 0.3¢ 0.3¢ $1.937K 645.7K

Buyers (Bids)

No. Vol. Price($)
77 96988980 0.2¢
 

Sellers (Offers)

Price($) Vol. No.
0.3¢ 655773 2
View Market Depth
Last trade - 10.00am 15/11/2024 (20 minute delay) ?
ATH (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.